Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 523

1.

Does stopping at C7 in long posterior cervical fusion accelerate the symptomatic breakdown of cervicothoracic junction?

Lee DH, Cho JH, Jung JI, Baik JM, Jun DS, Hwang CJ, Lee CS.

PLoS One. 2019 May 31;14(5):e0217792. doi: 10.1371/journal.pone.0217792. eCollection 2019.

2.

Validation of the Korean Stroop Test in Diagnosis of Minimal Hepatic Encephalopathy.

Yoon EL, Jun DW, Jeong JY, Kim TY, Song DS, Ahn SB, Kim HY, Jung YK, Song MJ, Kim SE, Kim HS, Jeong SW, Kim SG, Lee TH, Cho YK, Kim JK, Ryu H.

Sci Rep. 2019 May 29;9(1):8027. doi: 10.1038/s41598-019-44503-w.

3.

Inhibition of mixed lineage kinase domain like pseudokinase decreases fat de novo synthesis and chemokine ligand expression in non-alcoholic fatty liver disease.

Saeed WK, Jun DW, Jang K, Oh JH, Chae YJ, Lee JS, Koh DH, Kang HT.

J Gastroenterol Hepatol. 2019 May 27. doi: 10.1111/jgh.14740. [Epub ahead of print]

PMID:
31132314
4.

Surface screening, molecular modeling and in vitro studies on the interactions of aflatoxin M1 and human enzymes acetyl- and butyrylcholinesterase.

de Almeida JSFD, Cavalcante SFA, Dolezal R, Kuca K, Musilek K, Jun D, França TCC.

Chem Biol Interact. 2019 May 14;308:113-119. doi: 10.1016/j.cbi.2019.05.022. [Epub ahead of print]

PMID:
31100275
5.

Psoas muscle fluorine-18-labelled fluoro-2-deoxy-d-glucose uptake associated with the incidence of existing and incipient metabolic derangement.

Kim JY, Jun DW, Choi J, Nam E, Son D, Choi YY.

J Cachexia Sarcopenia Muscle. 2019 May 15. doi: 10.1002/jcsm.12430. [Epub ahead of print]

6.

Direct grafting of tetraaniline via perfluorophenylazide photochemistry to create antifouling, low bio-adhesion surfaces.

Lin CW, Aguilar S, Rao E, Mak WH, Huang X, He N, Chen D, Jun D, Curson PA, McVerry BT, Hoek EMV, Huang SC, Kaner RB.

Chem Sci. 2019 Mar 13;10(16):4445-4457. doi: 10.1039/c8sc04832k. eCollection 2019 Apr 28.

7.

Low-Dose Propranolol as Secondary Prophylaxis for Varix Bleeding Decreases Mortality and Rebleeding Rate in Patients with Tense Ascites.

Park JH, Jun DW, Choi J, Koh DH, Yoon JH, Lee KN, Lee HL, Lee OY, Yoon BC, Choi HS.

J Clin Med. 2019 Apr 26;8(5). pii: E573. doi: 10.3390/jcm8050573.

8.

In Vitro and In Silico Acetylcholinesterase Inhibitory Activity of Thalictricavine and Canadine and Their Predicted Penetration across the Blood-Brain Barrier.

Chlebek J, Korábečný J, Doležal R, Štěpánková Š, Pérez DI, Hošťálková A, Opletal L, Cahlíková L, Macáková K, Kučera T, Hrabinová M, Jun D.

Molecules. 2019 Apr 5;24(7). pii: E1340. doi: 10.3390/molecules24071340.

9.

Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease.

Ahn SB, Jun DW, Kang BK, Lim JH, Lim S, Chung MJ.

Sci Rep. 2019 Apr 5;9(1):5688. doi: 10.1038/s41598-019-42059-3.

10.

Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.

Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, Fujii H, Wu Y, Kam LY, Ji F, Li X, Chien N, Wei M, Ogawa E, Zhao C, Wu X, Stave CD, Henry L, Barnett S, Takahashi H, Furusyo N, Eguchi Y, Hsu YC, Lee TY, Ren W, Qin C, Jun DW, Toyoda H, Wong VW, Cheung R, Zhu Q, Nguyen MH.

Lancet Gastroenterol Hepatol. 2019 May;4(5):389-398. doi: 10.1016/S2468-1253(19)30039-1. Epub 2019 Mar 20.

PMID:
30902670
11.

N-alkylated Tacrine Derivatives as Potential Agents in Alzheimer's Disease Therapy.

Nepovimova E, Korabecny J, Hepnarova V, Jun D, Dolezal R, Muckova L, Jost P, Soukup O, Janockova J, Pham NL, Nguyen TD, Valis M, Kuca K.

Curr Alzheimer Res. 2019;16(4):333-343. doi: 10.2174/1567205016666190314163942.

PMID:
30873921
12.

Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease.

Chalupova K, Korabecny J, Bartolini M, Monti B, Lamba D, Caliandro R, Pesaresi A, Brazzolotto X, Gastellier AJ, Nachon F, Pejchal J, Jarosova M, Hepnarova V, Jun D, Hrabinova M, Dolezal R, Zdarova Karasova J, Mzik M, Kristofikova Z, Misik J, Muckova L, Jost P, Soukup O, Benkova M, Setnicka V, Habartova L, Chvojkova M, Kleteckova L, Vales K, Mezeiova E, Uliassi E, Valis M, Nepovimova E, Bolognesi ML, Kuca K.

Eur J Med Chem. 2019 Apr 15;168:491-514. doi: 10.1016/j.ejmech.2019.02.021. Epub 2019 Feb 27.

PMID:
30851693
13.

Some Possibilities to Study New Prophylactics against Nerve Agents.

Bajgar J, Kassa J, Kucera T, Musilek K, Jun D, Kuca K.

Mini Rev Med Chem. 2019 Feb 28. doi: 10.2174/1389557519666190301112530. [Epub ahead of print]

PMID:
30827238
15.

Are Measures of Postural Behavior Using Motion Sensors in Seated Office Workers Reliable?

Jun D, Johnston V, McPhail SM, O'Leary S.

Hum Factors. 2019 Feb 7:18720818821273. doi: 10.1177/0018720818821273. [Epub ahead of print]

PMID:
30730777
16.

Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's Disease.

Hostalkova A, Marikova J, Opletal L, Korabecny J, Hulcova D, Kunes J, Novakova L, Perez DI, Jun D, Kucera T, Andrisano V, Siatka T, Cahlikova L.

J Nat Prod. 2019 Feb 22;82(2):239-248. doi: 10.1021/acs.jnatprod.8b00592. Epub 2019 Jan 31.

PMID:
30701972
17.

Oxidative stress induced by oxime reactivators of acetylcholinesterase in vitro.

Muckova L, Vanova N, Misik J, Herman D, Pejchal J, Jun D.

Toxicol In Vitro. 2019 Apr;56:110-117. doi: 10.1016/j.tiv.2019.01.013. Epub 2019 Jan 23.

PMID:
30682493
18.

Feasibility and Stability of Liver Biopsy before Treatment for Preclinical Nonalcoholic Fatty Liver Studies.

Chae YJ, Jun DW, Saeed WK, Kang HT, Oh JH, Lee SM, Jang K.

J Korean Med Sci. 2019 Jan 3;34(2):e14. doi: 10.3346/jkms.2019.34.e14. eCollection 2019 Jan 14.

19.

Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease.

Saeed WK, Jun DW, Jang K, Ahn SB, Oh JH, Chae YJ, Lee JS, Kang HT.

World J Gastroenterol. 2018 Dec 28;24(48):5477-5490. doi: 10.3748/wjg.v24.i48.5477.

20.

The Use of Foxa2-Overexpressing Adipose Tissue-Derived Stem Cells in a Scaffold System Attenuates Acute Liver Injury.

Chae YJ, Jun DW, Lee JS, Saeed WK, Kang HT, Jang K, Lee JH.

Gut Liver. 2019 Mar 15. doi: 10.5009/gnl18235. [Epub ahead of print]

21.

Evaluation of the subtle effects and oxidative stress response of chloramphenicol, thiamphenicol, and florfenicol in Daphnia magna.

Yuxuan Z, Peiyong G, Yanmei W, Xiaoyan Z, Meixian W, Simin Y, Yinshi S, Jun D, Haitao S.

Environ Toxicol Chem. 2019 Mar;38(3):575-584. doi: 10.1002/etc.4344. Epub 2019 Feb 18.

PMID:
30569581
22.

[Changes of brain CT imaging of cerebral cysticercosis patients during the period of anti-cysticercus chemotherapy].

Ying-Xin H, Feng-Ju J, Hua T, Zhen-Hua Y, Jun D, Tao Y.

Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2018 Oct 19;30(5):523-526. doi: 10.16250/j.32.1374.2018016. Chinese.

PMID:
30567023
23.

Oxime K203: a drug candidate for the treatment of tabun intoxication.

Gorecki L, Soukup O, Kucera T, Malinak D, Jun D, Kuca K, Musilek K, Korabecny J.

Arch Toxicol. 2019 Mar;93(3):673-691. doi: 10.1007/s00204-018-2377-7. Epub 2018 Dec 18.

PMID:
30564897
24.

Optimal cutoff value for assessing changes in intrahepatic fat amount by using the controlled attenuation parameter in a longitudinal setting.

Ahn SB, Jun DW, Kang BK, Kim M, Chang M, Nam E.

Medicine (Baltimore). 2018 Dec;97(50):e13636. doi: 10.1097/MD.0000000000013636.

25.

Presence of Sarcopenia and Its Rate of Change Are Independently Associated with Long-term Mortality in Patients with Liver Cirrhosis.

Jeong JY, Lim S, Sohn JH, Lee JG, Jun DW, Kim Y.

J Korean Med Sci. 2018 Oct 31;33(50):e299. doi: 10.3346/jkms.2018.33.e299. eCollection 2018 Dec 10.

26.

Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer's disease therapy.

Dgachi Y, Martin H, Malek R, Jun D, Janockova J, Sepsova V, Soukup O, Iriepa I, Moraleda I, Maalej E, Carreiras MC, Refouvelet B, Chabchoub F, Marco-Contelles J, Ismaili L.

J Enzyme Inhib Med Chem. 2019 Dec;34(1):163-170. doi: 10.1080/14756366.2018.1538136.

27.

Effect of Stem Cell Treatment on Acute Liver Failure Model Using Scaffold.

Kang HT, Jun DW, Jang K, Hoh JK, Lee JS, Saeed WK, Chae YJ, Lee JH.

Dig Dis Sci. 2019 Mar;64(3):781-791. doi: 10.1007/s10620-018-5363-2. Epub 2018 Nov 12.

PMID:
30421375
28.

Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease.

Kwon I, Jun DW, Moon JH.

Gut Liver. 2019 May 15;13(3):308-314. doi: 10.5009/gnl18175.

29.

Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis.

Ju YC, Jun DW, Choi J, Saeed WK, Lee HY, Oh HW.

World J Gastroenterol. 2018 Oct 28;24(40):4606-4614. doi: 10.3748/wjg.v24.i40.4606.

30.

Tubular organotypic culture model of human kidney.

Jun DY, Kim SY, Na JC, Lee HH, Kim J, Yoon YE, Hong SJ, Han WK.

PLoS One. 2018 Oct 31;13(10):e0206447. doi: 10.1371/journal.pone.0206447. eCollection 2018.

31.

[Study on diagnosis of atypical cerebral cysticercosis].

Tao Y, Feng-Quan X, Yan W, Yu-Guang F, Jun D, Ting-Xia F.

Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2018 May 24;30(4):424-427. doi: 10.16250/j.32.1374.2018015. Chinese.

PMID:
30350507
32.

Novel quinazolin-4-one derivatives as potentiating agents of doxorubicin cytotoxicity.

Pospisilova M, Andrs M, Seifrtova M, Havelek R, Jun D, Tomsik P, Prchal L, Dolezal R, Tichy A, Kucera T, Korabecny J, Rezacova M.

Bioorg Chem. 2019 Feb;82:204-210. doi: 10.1016/j.bioorg.2018.10.001. Epub 2018 Oct 6.

PMID:
30326402
33.

Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease: Review and meta-analyses.

Ahn J, Jun DW, Lee HY, Moon JH.

Clin Nutr. 2018 Sep 25. pii: S0261-5614(18)32460-9. doi: 10.1016/j.clnu.2018.09.022. [Epub ahead of print]

PMID:
30314924
34.

Cytoprotective effect of 2-carbomethoxy-2,3-epoxy-3-prenyl-1,4-naphthoquinone (CMEP-NQ) is mediated by the inhibition of BAK-dependent mitochondrial apoptosis pathway.

Jun DY, Jang WY, Kim KY, Woo MH, Kim YH.

PLoS One. 2018 Oct 1;13(10):e0204585. doi: 10.1371/journal.pone.0204585. eCollection 2018.

35.

Molecular Modeling Studies on the Interactions of Aflatoxin B1 and Its Metabolites with Human Acetylcholinesterase. Part II: Interactions with the Catalytic Anionic Site (CAS).

de Almeida JSFD, Dolezal R, Krejcar O, Kuca K, Musilek K, Jun D, França TCC.

Toxins (Basel). 2018 Sep 25;10(10). pii: E389. doi: 10.3390/toxins10100389.

36.

FXR Inhibits Endoplasmic Reticulum Stress-Induced NLRP3 Inflammasome in Hepatocytes and Ameliorates Liver Injury.

Han CY, Rho HS, Kim A, Kim TH, Jang K, Jun DW, Kim JW, Kim B, Kim SG.

Cell Rep. 2018 Sep 11;24(11):2985-2999. doi: 10.1016/j.celrep.2018.07.068.

37.

Novel Group of AChE Reactivators-Synthesis, In Vitro Reactivation and Molecular Docking Study.

Malinak D, Nepovimova E, Jun D, Musilek K, Kuca K.

Molecules. 2018 Sep 7;23(9). pii: E2291. doi: 10.3390/molecules23092291.

38.

A Model to Predict 1-Month Risk of Transplant or Death in Hepatitis A-Related Acute Liver Failure.

Kim JD, Cho EJ, Ahn C, Park SK, Choi JY, Lee HC, Kim DY, Choi MS, Wang HJ, Kim IH, Yeon JE, Seo YS, Tak WY, Kim MY, Lee HJ, Kim YS, Jun DW, Sohn JH, Kwon SY, Park SH, Heo J, Jeong SH, Lee JH, Nakayama N, Mochida S, Ido A, Tsubouchi H, Takikawa H, Shalimar, Acharya SK, Bernal W, O'Grady J, Kim YJ.

Hepatology. 2018 Sep 8. doi: 10.1002/hep.30262. [Epub ahead of print]

PMID:
30194739
39.

Pharmacological target therapy of neuropathic pain and patient-reported outcomes in patients with chronic low back pain in Korea: Results from the NLBP Outcomes Research.

Hong JT, Kim JH, Kim KS, Lee CS, Shin HC, Kim WK, Kim JH, Lee JK, Kim IS, Ha Y, Im SB, Kim SW, Han IH, Shin JJ, Rim B, Suk KS, Kim JH, Park YS, Chang BS, Jun DS, Kim YH, Lee JH, Min WK, Lee JS, Park SY, Oh IS, Hong JY, Seo BJ, Kim YJ, Lee J.

Medicine (Baltimore). 2018 Aug;97(35):e11919. doi: 10.1097/MD.0000000000011919.

40.

Outcomes of underweight, overweight, and obese pediatric kidney transplant recipients.

Kaur K, Jun D, Grodstein E, Singer P, Castellanos L, Teperman L, Molmenti E, Fahmy A, Frank R, Infante L, Sethna CB.

Pediatr Nephrol. 2018 Dec;33(12):2353-2362. doi: 10.1007/s00467-018-4038-8. Epub 2018 Aug 22.

PMID:
30136105
41.

Fabrication of dihydroxyflavone-conjugated hyaluronic acid nanogels for targeted antitumoral effect.

Choi YR, Kim HJ, Ahn GY, Lee MJ, Park JR, Jun DR, Ryu TK, Park JW, Shin E, Choi SW.

Colloids Surf B Biointerfaces. 2018 Nov 1;171:690-697. doi: 10.1016/j.colsurfb.2018.08.003. Epub 2018 Aug 6.

PMID:
30114654
42.

The Peptidisc, a simple method for stabilizing membrane proteins in detergent-free solution.

Carlson ML, Young JW, Zhao Z, Fabre L, Jun D, Li J, Li J, Dhupar HS, Wason I, Mills AT, Beatty JT, Klassen JS, Rouiller I, Duong F.

Elife. 2018 Aug 15;7. pii: e34085. doi: 10.7554/eLife.34085.

43.

Recent research trends and updates on nonalcoholic fatty liver disease.

Yoo JJ, Kim W, Kim MY, Jun DW, Kim SG, Yeon JE, Lee JW, Cho YK, Park SH, Sohn JH; the Korean Association for the Study of the Liver (KASL)-Korea Nonalcoholic fatty liver Study Group (KNSG).

Clin Mol Hepatol. 2019 Mar;25(1):1-11. doi: 10.3350/cmh.2018.0037. Epub 2018 Aug 8.

44.

Purin-6-one and pyrrolo[2,3-d]pyrimidin-4-one derivatives as potentiating agents of doxorubicin cytotoxicity.

Andrs M, Pospisilova M, Seifrtova M, Havelek R, Tichy A, Vejrychova K, Polednikova M, Gorecki L, Jun D, Korabecny J, Rezacova M.

Future Med Chem. 2018 Sep 1;10(17):2029-2038. doi: 10.4155/fmc-2018-0086. Epub 2018 Aug 1.

PMID:
30067076
45.

Simultaneous determination of malondialdehyde and 3-nitrotyrosine in cultured human hepatoma cells by liquid chromatography-mass spectrometry.

Vanova N, Muckova L, Schmidt M, Herman D, Dlabkova A, Pejchal J, Jun D.

Biomed Chromatogr. 2018 Dec;32(12):e4349. doi: 10.1002/bmc.4349. Epub 2018 Aug 21.

PMID:
30051494
46.

Efficacy of Pegylated Interferon Monotherapy versus Sequential Therapy of Entecavir and Pegylated Interferon in Hepatitis B e Antigen-Positive Hepatitis B Patients: A Randomized, Multicenter, Phase IIIb Open-Label Study (POTENT Study).

Jun DW, Ahn SB, Kim TY, Sohn JH, Kim SG, Lee SW, Kim BH, Kim DJ, Kim JK, Kim HS, Hwang SG, Choi WC, Tak WY, Lee HJ, Yoon KT, Yun BC, Lee SW, Baik SK, Park SH, Park JW, Park SJ, Lee JS.

Chin Med J (Engl). 2018 Jul 20;131(14):1645-1651. doi: 10.4103/0366-6999.235880.

47.

Tacrine-coumarin and Tacrine-7-chloroquinoline Hybrids with Thiourea Linkers: Cholinesterase Inhibition Properties, Kinetic Study, Molecular Docking and Permeability Assay for Blood-brain Barrier.

Hamulakova S, Janovec L, Soukup O, Jun D, Janockova J, Hrabinova M, Sepsova V, Kuca K.

Curr Alzheimer Res. 2018;15(12):1096-1105. doi: 10.2174/1567205015666180711110750.

PMID:
29992880
48.

Effectiveness of tax credits for health insurance premium: Evidence from the health insurance tax credit.

Jun D.

Health Econ. 2018 Oct;27(10):1609-1616. doi: 10.1002/hec.3785. Epub 2018 Jun 19.

PMID:
29920847
49.

Vector Control and Insecticidal Resistance in the African Malaria Mosquito Anopheles gambiae.

Schmidt M, Hrabcova V, Jun D, Kuca K, Musilek K.

Chem Res Toxicol. 2018 Jul 16;31(7):534-547. doi: 10.1021/acs.chemrestox.7b00285. Epub 2018 Jun 15. Review.

PMID:
29847927
50.

Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience.

Chen VL, Yeh ML, Le AK, Jun M, Saeed WK, Yang JD, Huang CF, Lee HY, Tsai PC, Lee MH, Giama N, Kim NG, Nguyen PP, Dang H, Ali HA, Zhang N, Huang JF, Dai CY, Chuang WL, Roberts LR, Jun DW, Lim YS, Yu ML, Nguyen MH.

Aliment Pharmacol Ther. 2018 Jul;48(1):44-54. doi: 10.1111/apt.14801. Epub 2018 May 24.

PMID:
29797518

Supplemental Content

Support Center